secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECTIS HEALTH, INC. (GBCS)
CIK:        0000727346
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0001493152-24-039043
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Selectis Health raises CEO salary to $250K; CEO waives $30K board stipend
-------------------------------------------------------------------------

- CEO Adam Desmond's salary increased from $150,000 to $250,000 per annum, effective October 1, 2024.
- Desmond agreed to forgo the $7,500 quarterly Board compensation stipend ($30,000/year).
- Net annual increase in cash compensation is approximately $70,000 before other benefits.
- Salary adjustment approved by the Board of Directors on October 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727346/000149315224039043/0001493152-24-039043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727346/000149315224039043/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-039043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer